Pediatric Heart Pump to Let Kids Go Home While Waiting for Transplant
Official title: Development of a Novel Pediatric LVAD for Home Discharge of Children Awaiting Heart Transplant
Funded at Corvion, INC. · NIH-11407580 · Data updated 2026-11-12
A new ultra-low-power pediatric heart pump is being developed so children awaiting a heart transplant can go home or live with the device.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Corvion, INC. NIH-funded |
| Lab location | 1 site (Webster, United States) |
| Project start | August 10, 2026 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,499,984 |
| NIH project number | 1R44HL184709-01A1 |
| Project ID | NIH-11407580 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are children with end-stage heart failure who are either awaiting a heart transplant or may require long-term mechanical support.
✕Less likely to help
Children without end-stage heart failure or those not eligible for LVAD implantation would not benefit.
What this research studies
This project aims to create a pediatric left ventricular assist device (P-LVAD) that is small, implantable, and energy-efficient to allow children with end-stage heart failure to leave the hospital and live at home while awaiting a transplant or for long-term use. The device focuses on hemocompatibility and low power use to reduce the burden of bulky pumps and heavy batteries for kids. Researchers will advance the blood pump technology and integration with pediatric patients, aiming to improve quality of life and mobility during this challenging period. The work is conducted by Corventix? Corvion, Inc. under Greg Aber, and involves translating engineering advances into a clinically viable pediatric MCS option.
Why it matters
Potential benefit: If successful, this P-LVAD could dramatically improve quality of life for children awaiting heart transplant by enabling home care and greater daily activity.
How similar studies have gone: Current Berlin Heart devices require hospitalization; this project explores a smaller, energy-efficient alternative that could enable home use.
Where this research is happening
-
Corvion, INC.
Webster, United States Active
Researchers
- Principal investigator: Aber, Greg — Corvion, INC.
- Study coordinator: Aber, Greg
Related research
Other NIH-funded projects on the same topics.
-
Predicting acute rejection in children after heart transplant
A study to improve how doctors predict if a child who has had a heart transplant will have acute rejection using noninvasive blood markers and advanced heart MRI analysis.
-
Molecular mismatch as a marker of immune risk in heart transplant patients
A study to see if specific biological differences between donor and recipient hearts can predict immune reactions and guide personalized immunosuppression in people who receive heart transplants.
-
Fair and efficient heart transplant allocation using AI-powered continuous distribution
A NIH-funded project will develop fair and efficient computer-based methods to match donated hearts with patients needing transplants.
-
Better ways to find heart transplant rejection in children
This research aims to find less invasive and more accurate ways to detect when a child's body is rejecting a new heart.
-
Investigating a medication to protect kidney function in heart transplant patients
This study is looking at whether a medication called empagliflozin can help improve kidney health and overall well-being in heart transplant patients who are at risk for kidney and heart problems, and we're inviting Veterans to join us in this important research.
-
Discovering biomarkers to improve heart transplant outcomes
This study is looking at how new technologies can help find important signs in heart transplant patients to better predict and manage issues like rejection, so that doctors can provide more personalized care and improve recovery for those patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.